- 4.8Impact Factor
- 9.2CiteScore
- 20 daysTime to First Decision
Biomolecules, Volume 9, Issue 11
November 2019 - 112 articles
Cover Story: Plaques consisting of amyloid-β (Aβ) are a major pathological hallmark of Alzheimer´s disease. Aβ is derived by amyloidogenic APP processing and prevented by a non-amyloidogenic pathway. Methylxanthines like caffeine decrease Aβ levels by shifting APP processing to the non-amyloidogenic pathway by decreasing β- and increasing α-secretase activity. Other factors that are also in involved in neurodegenerative diseases, like cholesterol, reactive oxygen species, APP expression, and Aβ aggregation, were also positively affected. Similar mechanisms were observed for all analyzed methylxanthines. Although effect strengths were moderate, the integration of methylxanthines as part of a healthy diet should be considered, especially because of their cost effectiveness, availability, and modest side effects. View this paper.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Biomolecules - ISSN 2218-273X